BPC-157 (Body Protection Compound) — Dosing, Cycles, Half-Life & Side Effects
BPC-157 (Body Protection Compound) is a tissue-repair peptide with a half-life of 4 hours. IMPORTANT: Pentadecapeptide derived from human gastric juice with tissue healing properties demonstrated primarily in ANIMAL STUDIES. NO COMPLETED HUMAN CLINICAL TRIALS for musculoskeletal applications. FDA Category 2 substance (insufficient evidence - cannot be compounded). WADA Prohibited List 2024. Human safety and efficacy NOT fully established. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.
Quick Facts
| Class | Healing Peptides |
|---|---|
| Half-life | 4 hours |
| Hepatotoxicity | None |
| Suppression | 0/10 |
Typical Dosing Ranges
Common dose range: 250-500mcg/day (NOTE: No human dosing studies - extrapolated from animal data)
Cycle length: 4-12 weeks
Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.
Stacking Considerations
- No structural stacking blockers. Standard harm-reduction rules apply: minimize total androgen load, minimize oral exposure, and monitor bloodwork.
PCT Requirements
- Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
- Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.
Side Effect Profile
- NO COMPLETED HUMAN CLINICAL TRIALS for most applications
- FDA Category 2 - cannot be legally compounded
- WADA Prohibited List substance
- Requires subcutaneous or intramuscular injection
- Human safety profile NOT established
- Long-term effects unknown
Known Interactions
bpc157 + tb500
minor — synergisticHealing peptides with complementary mechanisms.
Recommendation: Safe to combine. Often used together for injury recovery.
Monitor: None specific
Related compounds
Monitoring (Bloodwork & Vitals)
- Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
- Lipid panel (total cholesterol, HDL, LDL, triglycerides)
- CBC (hemoglobin, hematocrit — watch for erythrocytosis)
- Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
- Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)
Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.
Frequently Asked Questions
What is the half-life of BPC-157 (Body Protection Compound)?
BPC-157 (Body Protection Compound) has a half-life of approximately 4 hours. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.
What is the typical dose range for BPC-157 (Body Protection Compound)?
Commonly reported ranges for BPC-157 (Body Protection Compound): 250-500mcg/day (NOTE: No human dosing studies - extrapolated from animal data). Cycle length: 4-12 weeks. These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.
Does BPC-157 (Body Protection Compound) suppress natural testosterone?
BPC-157 (Body Protection Compound) causes minimal suppression of the HPTA axis (score 0/10). PCT may still be advisable depending on stack and duration.
What is BPC-157 (Body Protection Compound) typically used for?
BPC-157 (Body Protection Compound) is commonly used for: EXPERIMENTAL ONLY - No proven human applications, Research purposes. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.
Is BPC-157 (Body Protection Compound) legal?
BPC-157 (Body Protection Compound) is a controlled substance in many jurisdictions (typically Schedule III in the US when it is an anabolic androgenic steroid). StackItSmart does not provide sourcing information. Possession, import, and use without a prescription carry legal consequences that vary by country and state.
Citations
- Sikiric P et al.. 2011. Curr Pharm Des — Gastric pentadecapeptide BPC 157 review; primarily animal studies
- He R et al.. 2022. Front Pharmacol — BPC-157 pharmacology review; IV t1/2 = 15.2 min in rats
- Sikiric P, Seiwerth S, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011. PMID: 21548867
- FDA Category 2 Classification - Nominated Bulk Drug Substances
- WADA Prohibited List 2024 - S0. Non-Approved Substances
Disclaimer
StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use BPC-157 (Body Protection Compound). Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.